申请人:Abbott Laboratories
公开号:US04608390A1
公开(公告)日:1986-08-26
Compounds of the formula ##STR1## where X is selected from hydrogen, C.sub.1 to C.sub.22 alkyl or alkenyl, or an electron withdrawing group; n=0 or 1 and m=0, 1, 2 or 3; but n and m are not O simultaneously; R.sub.1 and R.sub.2 independently are hydrogen, C.sub.1 to C.sub.6 alkyl, an electron withdrawing group, or R.sub.4 ; R.sub.3 is H, C.sub.1 to C.sub.6 alkyl or cycloalkyl, or R.sub.4 ; and R.sub.4 independently at each occurrence, has the formula ##STR2## where Y is hydrogen or an electron withdrawing group; and wherein M is a pharmaceutically acceptable cation, are potent inhibitors of lipoxygenase enzymes.
公式为##STR1##的化合物,其中X选择自氢、C.sub.1至C.sub.22烷基或烯基,或电子吸引基;n=0或1,m=0、1、2或3;但n和m不能同时为O;R.sub.1和R.sub.2独立地是氢、C.sub.1至C.sub.6烷基、电子吸引基或R.sub.4;R.sub.3是H、C.sub.1至C.sub.6烷基或环烷基,或R.sub.4;R.sub.4在每次出现时独立地具有公式##STR2##,其中Y是氢或电子吸引基;M是药学上可接受的阳离子,是脂氧合酶酶的有效抑制剂。